Enlivex is a clinical-stage immunotherapy company focused on macrophage reprogramming. It is developing Allocetra, a universal cell therapy aimed at restoring macrophages to their homeostatic state, ...

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the Israeli Ministry of Health authorized the initiation ...

Resolution Therapeutics Limited (“Resolution” or “Company”), a clinical-stage biopharmaceutical company focused on pioneering regenerative macrophage therapy (“RMT”) in inflammatory and fibrotic ...

Dr Rupy Aujla - also known as the Doctor's Kitchen described them as 'potently anti-inflammatory' and said they were easy to ...

The hotspot at chr3q28 sits between the GMNC and osteocrin (OSTN) genes. They are involved in DNA replication and dendritic ...

Researchers at the University of Kentucky are exploring new ways to use nanoparticles in combination with other materials as ...

Researchers at the University of Kentucky are exploring new ways to use nanoparticles in combination with other materials as ...

Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a leader in macrophage-focused therapeutics, today announced a strategic reprioritization of its pipeline, cessation of ...

Researchers at the University of Kentucky are exploring new ways to use nanoparticles in combination with other materials as ...

The Netherlands Cancer Institute has found that the estrous cycle stage significantly influences mammary tumors' sensitivity ...

"_blank">developed an ultrasound imaging technique to visualize the movement of a type of immune cell called a macrophage, which works to heal wounds and fight infections in the body. With a five-year ...

The Company's first-class scientific team continues to make good progress with CBR and, once sufficient resources are provided, the Company anticipates moving new CBR-based product candidates into ...